Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Regeneron Pharmaceuticals Inc
FDA Inspection
•Regeneron Pharmaceuticals Inc•October 18, 2019

FDA Inspection 1106821 - Regeneron Pharmaceuticals Inc - October 18, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Regeneron Pharmaceuticals Inc, with an inspection on October 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Regeneron Pharmaceuticals Inc
Inspection Date
October 18, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · 2d3aca16-4c83-4b48-914c-5f89d3ad6cde

Violation Codes1
21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.